News
A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others.
With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY) mazdutide as the first-ever dual GLP-1/glucagon ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results